NCT06536348

Brief Summary

This is an observational, cross-sectional study with a control group, with the general objective of developing and evaluating a national database, unprecedented in Brazil, containing clinical, epidemiological, motor, and non-motor aspects of Parkinson's disease (PD). The database will be open and accessible to national and international researchers in order to contribute to the advancement of research related to PD. The aim is to collect data, in a paired way, from a control group and an experimental group. Data collection will include the application of questionnaires, the execution of motor activities, and clinical scales. Information that can identify the participants will be removed from the database for later storage in a repository. Quantitative, qualitative, and descriptive variables from the database will be estimated in order to characterise and contrast the groups studied. The results of this study will contribute to a better characterization of the staging of PD as a function of the epidemiological, motor, and non-motor aspects evaluated, as well as to the development of technologies and methods that can be applied in clinical practice.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
958

participants targeted

Target at P75+ for all trials

Timeline
103mo left

Started May 2025

Longer than P75 for all trials

Geographic Reach
1 country

5 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress11%
May 2025Oct 2034

First Submitted

Initial submission to the registry

July 28, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 2, 2024

Completed
9 months until next milestone

Study Start

First participant enrolled

May 1, 2025

Completed
9.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2034

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2034

Last Updated

March 14, 2025

Status Verified

March 1, 2025

Enrollment Period

9.4 years

First QC Date

July 28, 2024

Last Update Submit

March 12, 2025

Conditions

Keywords

Parkinson's diseasemotor assessmentnon-motor assessmentdatabasecomputer visioninertial sensors

Outcome Measures

Primary Outcomes (34)

  • Sex

    Sex: male, female

    10 years

  • Age

    Age in years

    10 years

  • Length of schooling

    Length of schooling in years

    10 years

  • Weight

    Weight in kg

    10 years

  • Height

    Height in cm

    10 years

  • Blood type

    Blood type: A+, A-, B+, B-, O+, O-, AB+, AB-

    10 years

  • Economic Rating Score

    Economic rating as given by the Brazilian Economic Classification Criteria (Brazilian Criteria) - https://www.abep.org/criterioBr/01\_cceb\_2022\_eng.pdf

    10 years

  • Primary ICD

    Primary disorder classification according to the International Statistical Classification of Diseases and Related Health Problems (ICD) https://www.who.int/standards/classifications/classification-of-diseases

    10 years

  • Secondary ICDs

    Secondary disorder according to the International Statistical Classification of Diseases and Related Health Problems (ICD) https://www.who.int/standards/classifications/classification-of-diseases

    10 years

  • Medications in use

    name and daily dose of medications

    10 years

  • Family history related to the primary ICD

    Is there family history related to the primary ICD? (yes, no)

    10 years

  • Date of symptom onset related to the primary ICD

    date

    10 years

  • Date of diagnosis related to the primary ICD

    date

    10 years

  • Current city of residence

    City of residence in Brazil

    10 years

  • Current state of residence

    State of residence in Brazil

    10 years

  • Civil status

    married, single, divorced, and widowed

    10 years

  • Housing classification

    Housing classification by type of housing ownership rights: State-owned housing, Municipality-owned housing, Natural person's owned housing, Legal person's owned housing, Private renting, Other

    10 years

  • Household size

    The number of adults and children living in a home

    10 years

  • Laterality

    Laterality refers to the preference for using one side of the body over the other and is most commonly associated with hand dominance, such as being right-handed or left-handed, e.g., Right-handedness, Left-handedness, Ambidexterity, Mixed-handedness (Cross-dominance).

    10 years

  • Use of technology

    Verification if the participant has had contact with one of the following devices: mobile, personal computer, mouse, webcam, keyboard, microphone, earphone.

    10 years

  • Occupation

    Profession according to the Brazilian Classification of Occupation (https://www.mtecbo.gov.br/cbosite/pages/home.jsf)

    10 years

  • Monthly wage

    Monthly wage in Brazilian Reais

    10 years

  • Head movement amplitude

    Head movement amplitude in degrees

    10 years

  • Head movement speed

    Head movement speed in degrees per second

    10 years

  • Facial expression

    Facial expression evaluation according to the Facial Action Coding System (FACS)

    10 years

  • Saccadic eye movement

    Speed and regularity of eye movement (degrees per second and latency in ms)

    10 years

  • Smooth pursuit eye movement

    Smooth pursuit are quantified by the gain (how well the eyes follow the target in speed) and phase (distance to the target during pursuit)

    10 years

  • Handwriting movement analysis

    Handwriting speed (seconds) and quality

    10 years

  • MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)

    Clinical scale for measuring signs and symptoms of Parkinson's disease (https://www.movementdisorders.org/MDS/MDS-Rating-Scales/MDS-Unified-Parkinsons-Disease-Rating-Scale-MDS-UPDRS.htm?gad\_source=1\&gclid=CjwKCAjwnqK1BhBvEiwAi7o0X6DuHrFh3qftNQ1N9AGWMkFo4BpG6b3hAFWnoh2Dwu86DPY53ZXpKRoCBRYQAvD\_BwE) Each item of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale will be evaluated as 0: Normal; 1: Slight; 2: Mild; 3: Moderate; 4: Severe. The minimum value of the scale is 0, whereas the maximum value is 4. Higher scores mean a worse outcome.

    10 years

  • Depression

    Depression measured according to the Geriatric Depression Scale (GDS) https://geriatrictoolkit.missouri.edu/cog/GDS\_SHORT\_FORM.PDF The Geriatric Depression Scale has 15 items. The minimum total score is zero, and the maximum is 15. Higher scores mean a worse outcome.

    10 years

  • Visual Acuity

    Visual Acuity measured according to the Snellen test (https://www.ncbi.nlm.nih.gov/books/NBK558961/)

    10 years

  • Cognition

    Cognition measured according to the Montreal Cognitive Assessment (MOCA) scale The Montreal Cognitive Assessment (MoCA) is a 30-point test. The minimum total score is zero, and the maximum is 30. Higher scores mean a better outcome.

    10 years

  • Dysarthria

    Dysarthria measured according to the protocol for the evaluation of central dysartries in patients with Parkinson's Disease (https://doi.org/10.1590/S1516-18462011005000030)

    10 years

  • Hand movement

    Hand movement in degrees per second

    10 years

Study Arms (2)

Experimental group

Group of subjects with Parkinson's disease

Control group

Neurological healthy subjects

Eligibility Criteria

Age18 Years - 120 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

* Experimental group: Individuals diagnosed with Parkinson's disease * Control group: Individuals not having Parkinson's disease (PD) or other neurological disease that resembles PD;

You may qualify if:

  • Experimental group: (i) present a neurological diagnosis of Parkinson's disease; (ii) be classified between stages I to IV of the Hoehn \& Yahr Scale; (iii) have central visual acuity equal to or greater than 20/40 (equivalent to 0.50) in each eye or equal to or greater than 20/30 (equivalent to 0.66) in one eye according to the Snellen scale.
  • Control group: (i) not having a neurological diagnosis of Parkinson's disease or other neurological disease that resembles PD; (ii) have central visual acuity equal to or greater than 20/40 (equivalent to 0.50) in each eye or equal to or greater than 20/30 (equivalent to 0.66) in one eye according to the Snellen scale.

You may not qualify if:

  • For both groups, individuals who have other neurological or musculoskeletal diseases that interfere with the execution of the tests will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Laboratório de Análise de Movimento e Processamento de Sinais

Brasília, Federal District, 72220-275, Brazil

Location

Centro Universitário Araguaia (UniAraguaia)

Goiânia, Goiás, 74.223-060, Brazil

Location

Associação Parkinson Goiás

Goiânia, Goiás, 74265-320, Brazil

Location

Ambulatório de Doença de Parkinson e Distúrbios do Movimento do Hospital de Clínicas de Uberlândia

Uberlândia, Minas Gerais, 38405-318, Brazil

Location

Núcleo de Inovação e Avaliação Tecnológica em Saúde / Centre for Innovation and Technology Assessment in Health

Uberlândia, Minas Gerais, 38408-100, Brazil

Location

Related Publications (23)

  • Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE, Lang AE. Parkinson disease. Nat Rev Dis Primers. 2017 Mar 23;3:17013. doi: 10.1038/nrdp.2017.13.

    PMID: 28332488BACKGROUND
  • World Health Organization, Parkinson disease, 2023.

    BACKGROUND
  • Barbosa MT, Caramelli P, Maia DP, Cunningham MC, Guerra HL, Lima-Costa MF, Cardoso F. Parkinsonism and Parkinson's disease in the elderly: a community-based survey in Brazil (the Bambui study). Mov Disord. 2006 Jun;21(6):800-8. doi: 10.1002/mds.20806.

    PMID: 16482566BACKGROUND
  • Vale TC, Barbosa MT, Resende EPF, Maia DP, Cunningham MCQ, Guimaraes HC, Machado JCB, Teixeira AL, Cardoso F, Caramelli P. Parkinsonism in a population-based study of individuals aged 75+ years: The Pieta study. Parkinsonism Relat Disord. 2018 Nov;56:76-81. doi: 10.1016/j.parkreldis.2018.06.030. Epub 2018 Jun 19.

    PMID: 29934195BACKGROUND
  • Simon DK, Tanner CM, Brundin P. Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology. Clin Geriatr Med. 2020 Feb;36(1):1-12. doi: 10.1016/j.cger.2019.08.002. Epub 2019 Aug 24.

    PMID: 31733690BACKGROUND
  • Obeso JA, Rodriguez-Oroz MC, Rodriguez M, Lanciego JL, Artieda J, Gonzalo N, Olanow CW. Pathophysiology of the basal ganglia in Parkinson's disease. Trends Neurosci. 2000 Oct;23(10 Suppl):S8-19. doi: 10.1016/s1471-1931(00)00028-8.

    PMID: 11052215BACKGROUND
  • Tysnes OB, Storstein A. Epidemiology of Parkinson's disease. J Neural Transm (Vienna). 2017 Aug;124(8):901-905. doi: 10.1007/s00702-017-1686-y. Epub 2017 Feb 1.

    PMID: 28150045BACKGROUND
  • Dickson JM, Grunewald RA. Somatic symptom progression in idiopathic Parkinson's disease. Parkinsonism Relat Disord. 2004 Dec;10(8):487-92. doi: 10.1016/j.parkreldis.2004.05.005.

    PMID: 15542009BACKGROUND
  • Cabral AM, Lora-Millan JS, Pereira AA, Rocon E, Andrade AO. On the Effect of Vibrotactile Stimulation in Essential Tremor. Healthcare (Basel). 2024 Feb 9;12(4):448. doi: 10.3390/healthcare12040448.

    PMID: 38391822BACKGROUND
  • Cardoso Mendes L, Abreu Rosa de Sa A, Alves Marques I, Morere Y, de Oliveira Andrade A. RehaBEElitation: the architecture and organization of a serious game to evaluate motor signs in Parkinson's disease. PeerJ Comput Sci. 2023 Mar 15;9:e1267. doi: 10.7717/peerj-cs.1267. eCollection 2023.

    PMID: 37346638BACKGROUND
  • S. Costa, I. A. Marques, A. Bevilaqua, A. Rabelo, L. Luiz, A. Cabral, N. Faustino, M. Okereke, M. Fraga Vieira e A. de Oliveira Andrade, "Biomechanical Evaluation of an Exoskeleton for Rehabilitation of Individuals with Parkinson's Disease," IRBM, vol. 44, p. 100741, February 2023

    BACKGROUND
  • L. C. Mendes, A. M. Cabral, C. M. Alves, Y. Morère e A. de Oliveira Andrade, "Objective assessment of tremor in Parkinson's disease using the RehaBEElitation serious game," em 2023 IEEE International Conference on Metrology for eXtended Reality, Artificial Intelligence and Neural Engineering (MetroXRAINE), 2023

    BACKGROUND
  • Mendes LC, Marques IA, Alves CM, Vieira MF, Junior EAL, Pereira AA, Naves ELM, Oliveira FHM, Bourhis G, Pino P, Morere Y, Andrade AO. Multidimensional Assessment of Individuals with Parkinson's Disease: Development and Structure Validation of a Self-Assessment Questionnaire. Healthcare (Basel). 2022 Sep 21;10(10):1823. doi: 10.3390/healthcare10101823.

    PMID: 36292272BACKGROUND
  • Nobrega LR, Rocon E, Pereira AA, Andrade AO. A Novel Physical Mobility Task to Assess Freezers in Parkinson's Disease. Healthcare (Basel). 2023 Jan 31;11(3):409. doi: 10.3390/healthcare11030409.

    PMID: 36766984BACKGROUND
  • L. C. Mendes, A. Moura Cabral, C. M. Alves, Y. Morere, I. A. Marques e A. de Oliveira Andrade, "Objective Evaluation of Bradykinesia Using the RehaBEElitation Serious Game," em 2022 IEEE Workshop on Complexity in Engineering (COMPENG), 2022.

    BACKGROUND
  • Machado AR, Zaidan HC, Paixao AP, Cavalheiro GL, Oliveira FH, Junior JA, Naves K, Pereira AA, Pereira JM, Pouratian N, Zhuo X, O'Keeffe A, Sharim J, Bordelon Y, Yang L, Vieira MF, Andrade AO. Feature visualization and classification for the discrimination between individuals with Parkinson's disease under levodopa and DBS treatments. Biomed Eng Online. 2016 Dec 30;15(1):169. doi: 10.1186/s12938-016-0290-y.

    PMID: 28038673BACKGROUND
  • Rabelo AG, Neves LP, Paixao APS, Oliveira FHM, de Souza LAPS, Vieira MF, Pereira AA, Andrade AO. Objective Assessment of Bradykinesia Estimated from the Wrist Extension in Older Adults and Patients with Parkinson's Disease. Ann Biomed Eng. 2017 Nov;45(11):2614-2625. doi: 10.1007/s10439-017-1908-3. Epub 2017 Aug 29.

    PMID: 28852889BACKGROUND
  • L. C. V. Ferreira, A. G. Rabelo, M. F. Vieira, A. A. Pereira e A. d. O. Andrade, "Gait variability and symmetry assessment with inertial sensors for quantitative discrimination of Trendelenburg sign in total hip arthroplasty patients: a pilot study based on convenience sampling," Research on Biomedical Engineering, vol. 34, p. 65-72, March 2018.

    BACKGROUND
  • Oliveira FHM, Machado ARP, Andrade AO. On the Use of t-Distributed Stochastic Neighbor Embedding for Data Visualization and Classification of Individuals with Parkinson's Disease. Comput Math Methods Med. 2018 Nov 4;2018:8019232. doi: 10.1155/2018/8019232. eCollection 2018.

    PMID: 30532798BACKGROUND
  • National Commission for the Incorporation of Technologies in the SUS - CONITEC, Clinical Protocol and Therapeutic Guidelines Parkinson's Disease, 2017.

    BACKGROUND
  • A. S. Fracassi, A. R. Gatto, S. Weber, A. A. Spadotto, P. W. Ribeiro and A. O. Schelp,

    BACKGROUND
  • Woo EH, White P, Lai CW. Ergonomics standards and guidelines for computer workstation design and the impact on users' health - a review. Ergonomics. 2016 Mar;59(3):464-75. doi: 10.1080/00140139.2015.1076528. Epub 2015 Sep 24.

    PMID: 26224145BACKGROUND
  • J. F. Cecato, J. M. Montiel, D. Bartholomeu and J. E. Martinelli,

    BACKGROUND

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Officials

  • Adriano Andrade, PhD

    Federal University of Uberlandia

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Adriano Andrade, PhD

CONTACT

Adriano Andrade, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 28, 2024

First Posted

August 2, 2024

Study Start

May 1, 2025

Primary Completion (Estimated)

October 1, 2034

Study Completion (Estimated)

October 1, 2034

Last Updated

March 14, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will share

The data will be anonymised, stored in a safe and international plataform (Zenodo - https://github.com/NIATS-UFU). Only information that can be used to identify the subjects will be shared.

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
Starting 6 months after publication
Access Criteria
Researchers that wish to have access to the data can request access at https://github.com/NIATS-UFU. Full access will be granted for research purposes.

Locations